Clinical Chemistry

C-Peptide Test Essential after Type 1 Diabetes Diagnosis
C-peptide testing a few years after a diagnosis of type 1 diabetes should be a routine procedure as it can help pinpoint occasional patients who have been misdiagnosed and actually have type 2 diabetes or a monogenic form of the disease. More...03 Apr 2019

Increased Hormones Lead to Idiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension, also known as IIH, is caused by high pressure in the brain with consequences from blindness to incapacitating daily long-term headaches. Patients have reduced quality of life due to chronic headaches and papilledema-induced visual loss which is permanent in 25% of patients. More...02 Apr 2019

Signature Odor of Parkinson's Disease Discovered
Parkinson's disease is a neurodegenerative disorder that leads to progressive brain cell death and extensive loss of motor function. Despite many investigations being conducted on this disease, there are no definitive diagnostic tests currently available. More...02 Apr 2019

Metabolic Fingerprinting Diagnoses Fibromyalgia
Fibromyalgia is the most common cause of chronic widespread pain in the USA, and disproportionately affects women. It is estimated that about 2% of the population, around four million adults, has fibromyalgia; however some organizations estimate even higher numbers. More...02 Apr 2019

HbA1c Test Misses Many Cases of Diabetes
A glucose tolerance test, also known as the oral glucose tolerance test, measures the body's response to sugar (glucose). In this test, a person's blood is taken after an overnight fast, and then again two hours after they drink a sugary drink. The glucose tolerance test can be used to screen for type 2 diabetes. More...02 Apr 2019


Blood Test to Diagnose Heart Attacks Can Be Misleading
The use of increasingly sensitive troponin assays for excluding or diagnosing acute myocardial infarction has become universal. A diagnosis of acute myocardial infarction is defined, in the context of an appropriate clinical presentation, by a rise or fall in cardiac troponin concentration, now the gold standard biomarker. More...27 Mar 2019
In Other News
Urine Test Allows for Rapid Preeclampsia Diagnosis
Diabetics Experience High Blood Sugar after Joint Surgery
Proteomics Profile Early Detection Ovarian Cancer
Urinary KIM-1 Concentration Interpreted in Detecting AKI
Biochemical Monitoring Devices Measure Analytes in Perspiration
Glycemic Variability Predicts Major Adverse Cardiac Event
Fecal Immunochemical Tests Performance Characterized for CRC
HbA1c Levels May Help Predict CF-Related Diabetes
Nanopatterned Microfluidic Chip Detects Cancer Markers
Analysis Compared for Accurate Pleural Fluid pH Determination
Blood Test Identifies Amino Acid Metabotypes Associated with Autism
Vitamin D Measured in Human Hair
Blood Test Detects Alzheimer's Disease before Symptoms Appear
Procalcitonin Evaluated as Sepsis Diagnostic Marker
Simple Bile Acid Blood Test Predicts Stillbirth Risk
HDL Cholesterol Measurement Unaffected by Serum Amyloid A
Markers in Male Reproductive Impairments Causing Miscarriages
Protein Linked to Increased Risk for CVD and Stroke
Sweat Chloride Quantified Using Capillary Electrophoresis
New Glucose Biosensor Introduced for Diabetes Management
HDL Subclasses Linked to Mortality in Heart Failure Patients
Long-Term Risk for CVD Stratified by Fasting Glucose Level
High-Sensitivity CRP Testing Underutilized
The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.